Cocrystal Pharma (COCP) Retained Earnings (2010 - 2026)
Cocrystal Pharma (COCP) posted Retained Earnings of -$344.5 million for Q1 2026, down 0.67% sequentially from -$342.2 million in Q4 2025, and down 2.63% YoY from -$353.9 million in Q1 2025.
Cocrystal Pharma (COCP) Retained Earnings (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported Retained Earnings for 17 years, with the latest figure at -$344.5 million in Q1 2026.
- Quarterly Retained Earnings fell 2.63% year-over-year to -$344.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$344.5 million (down 2.63% YoY) and the FY2025 annual result came in at -$342.2 million, down 2.65% from the prior year.
- Retained Earnings declined to -$344.5 million in Q1 2026 per COCP's latest filing, from -$342.2 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$263.3 million in Q1 2022 and troughed at -$344.5 million in Q1 2026.
- A 5-year average of -$317.0 million and a median of -$319.9 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2026: Retained Earnings decreased 15.12% in 2023, then dropped 2.63% in 2026.
- Over 5 years, Retained Earnings stood at -$297.9 million in 2022, then decreased by 6.04% to -$315.9 million in 2023, then decreased by 5.54% to -$333.4 million in 2024, then declined by 2.65% to -$342.2 million in 2025, then dropped by 0.67% to -$344.5 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$344.5 million, -$342.2 million, and -$339.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | -347.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -347.71 Mn |
| Mar 31, 2026 | -344.55 Mn |
| Dec 31, 2025 | -342.25 Mn |
| Sep 30, 2025 | -339.82 Mn |
| Jun 30, 2025 | -337.77 Mn |
| Mar 31, 2025 | -335.72 Mn |
| Dec 31, 2024 | -333.42 Mn |
| Sep 30, 2024 | -330.15 Mn |
| Jun 30, 2024 | -325.21 Mn |
| Mar 31, 2024 | -319.87 Mn |
| Dec 31, 2023 | -315.91 Mn |
| Sep 30, 2023 | -311.45 Mn |
| Jun 30, 2023 | -307.29 Mn |
| Mar 31, 2023 | -303.12 Mn |
| Dec 31, 2022 | -297.93 Mn |
| Sep 30, 2022 | -293.43 Mn |
| Jun 30, 2022 | -287.73 Mn |
| Mar 31, 2022 | -263.30 Mn |
| Dec 31, 2021 | -259.09 Mn |
| Sep 30, 2021 | -255.41 Mn |